Back to News

The AirPods Pro 2 are still on sale - here's why they're legit in 2025

ZDNet - Artificial Intelligence
Jul 22, 2025 09:45
1 views
aibusinessenterprisetechnology

Summary

The article highlights that Apple's AirPods Pro 2 continue to be top contenders in the earbud market, offering advanced features at a competitive price. Their integration of AI-powered noise cancellation and adaptive audio technologies demonstrates Apple's ongoing commitment to enhancing user experience through AI-driven innovation in consumer electronics.

Apple's premium AirPods Pro 2 remain some of the best earbuds on the market, especially in the under-$200 price point.
Read Full ArticleMore News

Related Articles

XRP vs Chainlink: Which Crypto Could Make You a Millionaire?

Analytics InsightJul 22

The article compares XRP and Chainlink, analyzing their potential to generate significant returns for investors. While primarily focused on cryptocurrency investment, it highlights how Chainlink’s AI-driven smart contract capabilities could play a pivotal role in the future of decentralized finance. This suggests that advancements in AI integration with blockchain technology may influence the success and adoption of such digital assets.

Skipped Early Cardano (ADA)? Don’t Miss Ruvi AI’s (RUVI) Audited Token While Still Cheap, Experts Say It’s Next to Rally

Analytics InsightJul 22

The article highlights Ruvi AI's (RUVI) audited token as a promising investment opportunity in the AI sector, drawing comparisons to the early days of Cardano (ADA). Experts suggest that RUVI's low current price and recent audit position it for significant growth, signaling increasing investor interest in AI-driven blockchain projects. This trend underscores the growing convergence of AI and blockchain technologies in the crypto market.

AI-Designed Drugs Can Target 'Undruggable' Proteins in Cancer and Alzheimer's

Hacker News - AIJul 22

AI-driven drug discovery is enabling the design of molecules that can target previously "undruggable" proteins involved in diseases like cancer and Alzheimer's. This breakthrough expands the range of treatable conditions and demonstrates AI's transformative potential in accelerating and broadening pharmaceutical innovation.